Bracing for Biomarkers

Premium

Biomarkers travel a long distance between their conception in a basic research lab and their eventual use as a clinical diagnostic. As chair of the clinical labs department at Memorial Sloan Kettering Cancer Center, Martin Fleisher spends a good amount of time thinking about biomarkers and the route they take to get to the clinic. GT’s Jeanene Swanson caught up with Fleisher to ask about how to spot a good biomarker, the rigors of validation, and more.

Genome Technology: What types of biomarkers are currently being used in clinical diagnostic labs?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.